Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia
Top Cited Papers
- 11 April 2013
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 121 (15), 3005-3015
- https://doi.org/10.1182/blood-2012-08-452938
Abstract
The natural course of chronic myelomonocytic leukemia (CMML) is highly variable but a widely accepted prognostic scoring system for patients with CMML is not available. The main aim of this study was to develop a new CMML-specific prognostic scoring system (CPSS) in a large series of 558 patients with CMML (training cohort, Spanish Group of Myelodysplastic Syndromes) and to validate it in an independent series of 274 patients (validation cohort, Heinrich Heine University Hospital, Düsseldorf, Germany, and San Matteo Hospital, Pavia, Italy). The most relevant variables for overall survival (OS) and evolution to acute myeloblastic leukemia (AML) were FAB and WHO CMML subtypes, CMML-specific cytogenetic risk classification, and red blood cell (RBC) transfusion dependency. CPSS was able to segregate patients into 4 clearly different risk groups for OS (P < .001) and risk of AML evolution (P < .001) and its predictive capability was confirmed in the validation cohort. An alternative CPSS with hemoglobin instead of RBC transfusion dependency offered almost identical prognostic capability. This study confirms the prognostic impact of FAB and WHO subtypes, recognizes the importance of RBC transfusion dependency and cytogenetics, and offers a simple and powerful CPSS for accurately assessing prognosis and planning therapy in patients with CMML.Keywords
This publication has 25 references indexed in Scilit:
- Revised International Prognostic Scoring System for Myelodysplastic SyndromesBlood, 2012
- Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)Haematologica, 2011
- Cytogenetic risk stratification in chronic myelomonocytic leukemiaHaematologica, 2010
- Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic SyndromesJournal of Clinical Oncology, 2007
- Concordance probability and discriminatory power in proportional hazards regressionBiometrika, 2005
- Two groups of chronic myelomonocytic leukaemia: myelodysplastic and myeloproliferative. Prognostic implications in a series of a single centerLeukemia Research, 2002
- New prognostic parameters for chronic myelomonocytic leukemia?Blood, 2002
- Problems in the classification of CMML—dysplastic versus proliferative typeLeukemia Research, 1998
- The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia: Proposals by the French ‐ American ‐ British Cooperative Leukaemia GroupBritish Journal of Haematology, 1994
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982